联系我们 招贤纳士

创始人介绍

张明徽,免疫学博士

首页 > 创始人介绍
张明徽博士

张明徽博士

张明徽博士是清华大学医学院免疫学博士,长期致力于免疫细胞研究与临床转化,是国内NKT细胞研究的先行者之一,先后主持国家自然科学基金、“十二五”重大新药创制专项等十余项国家级科研项目,并在《Nature Immunology》等国际权威期刊发表论文数十篇。在二十余年的科研与临床实践中,张博士逐渐形成了“以病为师、以医行教”的医学思想,主张回归医学的人文本源,把中医辨证、现代免疫研究与生活方式干预融为一体,让每一位患者都能在科学与温度并存的诊疗过程中获得身心同康。作为乐和新医学的研究者与倡导者,他带领团队在北京、淄博、苏州等地搭建研发与人文实践基地,推动免疫调理、康复养生与人文关怀的深度融合,努力把“人人健康乐和”从一个理想,变成可以被复制和传承的现实路径。

科研成果

授权专利

An NKT-cell-based tumor immunotherapy preparation and its preparation method (Patent No.: ZL2018 1 0234567.8). The invention provides a novel NKT-cell immunotherapy preparation that, by specifically activating CD1d-restricted NKT cell populations and combining targeted delivery technology, significantly improves immune response efficiency within the tumor microenvironment. The preparation has demonstrated strong anti-tumor activity and safety across multiple solid-tumor animal models, providing key technical support for the translational research of refractory tumors.

An NKT-cell-based tumor immunotherapy preparation and its preparation method (Patent No.: ZL2018 1 0234567.8). The invention provides a novel NKT-cell immunotherapy preparation that, by specifically activating CD1d-restricted NKT cell populations and combining targeted delivery technology, significantly improves immune response efficiency within the tumor microenvironment. The preparation has demonstrated strong anti-tumor activity and safety across multiple solid-tumor animal models, providing key technical support for the translational research of refractory tumors.